Isolation of Lautropia mirabilis from sputa of a cystic fibrosis patient by BenDekhil, S. M. et al.
JOURNAL OF CLINICAL MICROBIOLOGY,
0095-1137/97/$04.0010
Apr. 1997, p. 1024–1026 Vol. 35, No. 4
Copyright q 1997, American Society for Microbiology
Isolation of Lautropia mirabilis from Sputa
of a Cystic Fibrosis Patient
SUSAN M. BEN DEKHIL,1 MARGARET M. PEEL,2 VIRGINIA A. LENNOX,3
ERKO STACKEBRANDT,1† AND LINDSAY I. SLY1*
Australian Collection of Microorganisms, Centre for Bacterial Diversity and Identification, Department of Microbiology,
The University of Queensland, Brisbane,1 Microbiological Diagnostic Unit, Department of Microbiology, The University
of Melbourne, Melbourne,2 and Department of Microbiology, Royal North Shore Hospital, Sydney,3 Australia
Received 24 September 1996/Returned for modification 1 November 1996/Accepted 6 January 1997
An aggregate-forming coccus, isolated twice as the predominant microorganism in sputa from a cystic
fibrosis patient on consecutive days, was shown to belong to the species Lautropia mirabilis on the bases of
similarities of 16S rRNA gene sequences and phenotype. These isolates of L. mirabilis appear to be the first
reported from a patient with cystic fibrosis and outside of Denmark.
An aggregate-forming gram-negative coccoid bacterium was
isolated on two separate occasions in 1991 at the Royal North
Shore Hospital, Sydney, Australia, as the predominant bacte-
rium in sputum samples taken on consecutive days from a
35-year-old female patient with cystic fibrosis. The patient had
been admitted to the hospital for intravenous antibiotic ther-
apy for a chest infection in the upper lobe of both lungs. Her
medical history showed that she was diagnosed with cystic
fibrosis at 2 years of age when she presented with a failure to
thrive. She was treated with the pancreatic enzyme supplement
pancrelipase (Cotazym-S-Forte; Organon Australia Pty. Ltd.)
and remained healthy until she stopped taking the supplement
at 22 years of age. She subsequently developed steatorrhea and
insulin-dependent diabetes mellitis. At 27 years of age she
recommenced treatment with the pancreatic enzyme supple-
ment and the steatorrhea settled.
Microscopic examination of a Gram-stained smear of her
sputum taken on admission to the hospital showed numerous
pus cells, gram-negative rods, and gram-positive cocci. A heavy
growth of Haemophilus influenzae was cultured, along with a
light growth of both Staphylococcus aureus and Pseudomonas
aeruginosa. Burkholderia cepacia was not isolated. The patient
was commenced on imipenem treatment (500 mg, 4 times
daily) which was continued for 20 days. No maintenance anti-
biotics were given when she was finally discharged, and the
patient did not present for a follow-up examination.
The aggregate-forming, gram-negative coccoid bacterium
was first isolated on blood agar as the predominant microor-
ganism from a sputum sample taken after 14 days of hospital-
ization and 2 weeks of antibiotic treatment. A Gram-stain of
the sputum showed moderate numbers of pus cells and gram-
positive cocci only. However, the gram-negative coccus, along
with a moderate background of pseudomonads, yeasts, and
fungi, was cultured after 4 days of incubation. The same or-
ganism was isolated from a sputum sample taken the next day,
and as the patient was not responding adequately to the imi-
penem treatment, further investigation of the first isolate was
undertaken. Initial observation revealed superficial morpho-
logical similarity to the gram-negative agreggate-forming coc-
cus Morococcus cerebrosus ACM 858 (3). However, the aggre-
gate formations of the two bacteria are easily distinguishable
(Fig. 1). Thus, at the time of isolation the strain could not be
assigned to any recognized species. The strain was accessioned
into the Australian Collection of Microorganisms (Depart-
ment of Microbiology, University of Queensland) as strain
ACM 3763, and molecular characterization was undertaken to
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FIG. 1. Scanning electron micrographs showing the surface appearance of
colonies of L. mirabilis ACM 3763 (A) and M. cerebrosus ACM 858 (5ATCC
33486) (B).
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determine its phylogenetic position by comparison of its 16S
rRNA gene (rDNA) sequence with those of known species.
The extraction of genomic DNA and the amplification of the
16S rDNA was performed as described previously (1a). The
PCR products were purified by means of the Prep-A-Gene kit
(Bio-Rad, Hercules, Calif.), used as described by the manufac-
turer. The Taq DyeDeoxy Terminator Cycle Sequencing Kit
(Perkin-Elmer/Applied Biosystems, Foster City, Calif.) was
TABLE 1. Phenotypic comparison of case isolate ACM 3763, M. cerebrosus, and L. mirabilisa
Characteristic M. cerebrosus ACM 858(5ATCC 33486) Case isolate ACM 3763 L. mirabilis
Cell morphology
Gram reaction 2 2 2
Cell shape Polymorphic cocci in clusters Polymorphic cocci in clusters Polymorphic cocci in clusters
Cell size (mm) ,1 1–2 1–2 (occasionally .5)
Motility 2 1 1
Polysaccharide production on sucrose agar 1 1 1
Growth on:
Nutrient agar 1 1 1
Blood agar 1 1 1
Chocolate agar 1 1 1
Sucrose agar 1 1 1
MacConkey agar 2 2 2
Biochemical profile
Oxidase 1 1 1
Catalase 1 1 1
Hemolysis (horse blood) 1 1 2
Nitrate to nitrite 1/2 1 1
Nitrate to gas 1/2 2 1
Production of:
H2S from TSI
b 2 2 2
Phenylalanine deaminase 2 2 2
Urease (Christensen’s) 2 1 1
Decarboxylase test forc:
Arginine 2 2 2
Lysine 2 2 2
Ornithine 1 2 2
Hydrolysis of:
Esculin 2 1 1/2
Gelatin 2 2 2
Starch 2 2 2
Tween 80 2 2 2
Acid fromd:
Adonitol 2 2 2
Arabinose 2 2 2
Dulcitol 2 2 2
Fructose 1 1 1
Glucose 1 1 1
Inositol 2 2 2
Inulin 2 2 2
Lactose 2 2 2
Maltose 1 1 1
Mannitol 2 2 1/2
Raffinose 2 2 2
Rhamnose 2 2 2
Salicin 2 2 2
Sorbitol 2 2 2
Starch 2 2 2
Sucrose 1 1 1
Trehalose 2 2 2
Xylose 2 2 2
a Data are compiled from this study and references 2 (for L. mirabilis) and 3. 1, positive; 2, negative; 1/2, usually positive but sometimes negative.
b TSI, triple sugar iron agar.
cMoeller’s decarboxylase-dihydrolase test.
d Carbohydrates in peptone base with bromcresol purple indicator.
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used to directly sequence the PCR products, according to the
protocol provided by the manufacturer, and the reaction mix-
tures were sequenced automatically on an Applied Biosys-
tems model 373A DNA sequencer. The 16S rDNA sequence
was aligned manually against representative bacterial 16S
rDNA sequences contained in the Ribosomal Database
Project (4). Positions where length and sequence variations
made alignment uncertain were omitted from the analysis.
Pairwise sequence similarities showed that the isolate be-
longed to the beta-subclass of the class Proteobacteria and was
most closely related to a gram-negative aggregate-forming coc-
cus isolated from the oral cavity of humans in Denmark and
which was subsequently described as the type strain of Lau-
tropia mirabilis in 1994 (2).
Strain ACM 3763 was further characterized morphologi-
cally, and its biochemical profile was determined by a range of
conventional tests (2, 3) to allow a comparison with the de-
scription of L. mirabilis. These results are shown in Table 1,
along with those previously determined for M. cerebrosus (3)
and published for L. mirabilis (2). Table 2 shows their antibio-
grams, as determined by the disk diffusion technique.
The phylogenetic and phenotypic data support the identifi-
cation of the isolate from the cystic fibrosis patient as L. mira-
bilis. The analysis of 1,073 nucleotide positions of the 16S
rDNA sequence of strain ACM 3763 covering the region from
nucleotide 8 to 1073 (Escherichia coli numbering) showed
99.9% similarity to the sequence of the type strain of L. mira-
bilis, AB2188 (5NCTC 12852) (EMBL sequence accession
number X73223). Comparison with a partial 16S rDNA se-
quence for M. cerebrosus (1) over 306 nucleotide positions
showed only a distant phylogenetic relationship, with 80.2%
sequence similarity. The phenotypic characteristics presented
in Tables 1 and 2 are in close agreement with those of L.
mirabilis except for hemolysis on horse blood agar and gas
production from nitrate. The isolate was motile on isolation,
but several attempts in two laboratories to repeat the demon-
stration of motility were unsuccessful.
L. mirabilis was described (2) to include polymorphic gram-
negative cocci from the oral cavity and upper respiratory tract
which met Ørskov’s (5) description of “Sarcina mirabilis,” for
which no strains are extant. Strains assigned to L. mirabilis
were isolated from the oral cavity on Bordet-Gengou plates,
from a frontal sinus drain of a patient recovering from a strep-
tococcal sinusitis (2), and from the gingival margins of healthy
persons (6). Gerner-Smidt et al. considered that although no
evidence for pathogenicity exists, polysaccharide production
from sucrose by this oral bacterium is compatible with a pos-
sible role in the formation of dental plaque (2). There is also
no evidence at this stage that L. mirabilis is clinically significant
in cystic fibrosis. However, its occurrence in substantial num-
bers in the sputum of the patient in this study suggests that it
may colonize the respiratory tract and lungs of persons with
cystic fibrosis. It is hoped that this paper will alert clinical
microbiologists to this possibility and that an increased aware-
ness of this newly described organism will assist with the eval-
uation of its clinical significance.
Nucleotide sequence accession number. The rDNA se-
quence of L. mirabilis ACM 3763 determined in this study has
been deposited in the EMBL Database, Cambridge, United
Kingdom, under the accession number X97652.
Part of this research was funded by a University of Queensland
Special Project Grant to L.I.S. and E.S., and this is gratefully acknowl-
edged.
S.M.B.D. carried out the sequencing as part of a research project for
a Master of Scientific Studies and thanks Matthias Dorsch and Fred
Rainey for training in PCR and sequencing techniques. Michael No-
lan, Royal Brisbane Hospital, is thanked for a gift of imipenem disks.
REFERENCES
1. Ben Dekhil, S. M., E. Stackebrandt, and L. I. Sly. Unpublished data.
1a.Dorsch, M., and E. Stackebrandt. 1992. Some modifications in the procedure
of direct sequencing of PCR amplified 16S rDNA. J. Microbiol. Methods 16:
271–279.
2. Gerner-Smidt, P., H. Keiser-Nielsen, M. Dorsch, E. Stackebrandt, J. Ursing,
J. Blom, A. C. Christensen, J. J. Christensen, W. Frederiksen, S. Hoffmann,
W. Holten-Andersen, and Y. T. Ying. 1994. Lautropia mirabilis gen. nov., sp.
nov., a Gram-negative motile coccus with unusual morphology isolated from
the human mouth. Microbiology 140:1787–1797.
3. Long, P. A., L. I. Sly, A. V. Pham, and G. H. G. Davis. 1981. Characterization
of Morococcus cerebrosus gen. nov., sp. nov. and comparison with Neisseria
mucosa. Int. J. Syst. Bacteriol. 31:294–301.
4. Maidak, B. L., N. Larsen, M. J. McCaughey, R. Overbeek, G. J. Olsen, K.
Fogel, J. Blandy, and C. R. Woese. 1994. The Ribosomal Database Project.
Nucleic Acids Res. 22:3485–3487.
5. Ørskov, J. 1930. Untersuchungen u¨ber einen in Mundho¨hle und oberen
Luftwegen ha¨ufig vorkommenden, zur Sarcinagruppe geho¨rigen Mikroben,
der eigentu¨mliche morphologische Verha¨ltnisse aufweist. Acta Pathol. Micro-
biol. Scand. (Suppl. III):519–541.
6. Schio¨tt, C. R. 1967. An unidentified Gram negative rod isolated from the
gingiva. J. Periodontal Res. 2:242–243.
TABLE 2. Antimicrobial susceptibilities of case isolate
ACM 3763, M. cerebrosus, and L. mirabilis
Antimicrobial
agent
Susceptibility by disk diffusion
M. cerebrosus Case isolateACM 3763 L. mirabilis
resultcDisk
concn
Zone
sizea Result
b Disk
concn
Zone
size Result
Ampicillin 2 mg 8 S 2 mg 10 S S
Chloramphenicol 10 mg 11 S 10 mg 12 S NT
Erythromycin 15 mg 9 S 15 mg 10 S S
Gentamicin 10 mg 14 S 10 mg 11 S S
Methicillin 5 mg 0 R 5 mg 0 R NT
Nalidixic acid 30 mg 13 S 30 mg 12 S NT
Penicillin 10 U 9 S 1.5 U 10 S S
Tetracycline 10 mg 12 S 10 mg 12 S NT
Imipenem NT 10 mg 12 S NT
a Radius of inhibition zone (in millimeters).
b S, susceptible; R, resistant; NT, not tested.
c As reported in reference 2.
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